Angiocardiac Care of Texas, PA

Houston, Texas 77025 5253

1 studies enrolling now · 7 studies all time

What they study most

Acute Coronary Syndromes, Angina Pectoris, Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease, High Cardiovascular Risk, Lipoprotein Disorder, Obesity, Overweight, Type 2 Diabetes

Studies at this site

• Pelacarsen Roll-over Extension Program — Recruiting now
• A Study of DII235 in Adults With Elevated Lipoprotein(a) — Running, not enrolling
• Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD — Completed
• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity — Running, not enrolling
• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina — Completed